World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT02229305
Date of registration: 28/08/2014
Prospective Registration: No
Primary sponsor: Harvard University
Public title: Maine Implementation Study - Phase III
Scientific title: Child System and Treatment Enhancement Projects (Child STEPs); The Clinic Treatment Project in Maine - Phase III
Date of first enrolment: December 2008
Target sample size: 235
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT02229305
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment  
Phase:  N/A
Countries of recruitment
United States
Contacts
Name:     John R Weisz, PhD
Address: 
Telephone:
Email:
Affiliation:  Harvard University
Key inclusion & exclusion criteria

Inclusion Criteria:

- 6 - 15 year old and their caregivers

- seeking services at community mental health clinics

- primary problem or disorder related to anxiety, traumatic stress, depression, or
conduct problems, or any combination of the four problems

Exclusion Criteria:

- Child is younger than 6 years or older than 15 years on the day of the phone screen

- Child has attempted suicide within the past year

- Schizophrenic spectrum disorders (including MDD with psychotic features)

- Autism or another Pervasive Developmental Disorder (E.g., PDD NOS, Asperger's
Disorder, Child Disintegration Disorder, Rett's Disorder)

- Anorexia Nervosa

- Bulimia Nervosa

- Mental Retardation

- No relevant T-scores validate target disorders

- ADHD identified as primary reason for seeking treatment at phone screen

- Child's medication has not been regulated for one month or longer



Age minimum: 6 Years
Age maximum: 15 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Anxiety
Problem Behavior
Depression
Trauma
Intervention(s)
Behavioral: Modular Approach to Therapy for Children
Behavioral: Usual Care Treatment
Primary Outcome(s)
Brief Problem Checklist (BPC, parent and child forms) [Time Frame: Change over time from Day 1 to Day 242 (end of treatment)]
Top Problems Assessment [Time Frame: Change over time from Day 1 to Day 735 (24-month follow-up)]
Secondary Outcome(s)
Service Assessment for Children and Adolescents: Treatment and Auxiliary Service Use Scales [Time Frame: Change over tiem from Day 1 to Day 735 (24-month follow-up)]
UCLA PTSD Index [Time Frame: Change over time from Day 1 to Day 735 (24-month follow-up)]
Services for Children and Adolescents - Parent Interview (SCAPI) [Time Frame: Change over time from Day 1 to Day 735 (24-month follow-up)]
Youth Self Report (YSR) [Time Frame: Change over time from Day 1 to Day 735 (24-month follow-up)]
Child Behavior Checklist [Time Frame: Change over time from Day 1 to Day 735 (24-month follow-up)]
Therapeutic Alliance Scale for Children [Time Frame: Post-treatment (Day 267)]
Brief Impairment Scale [Time Frame: Change over time from Day 1 to Day 735 (24-month follow-up)]
Secondary ID(s)
STEPs Phase III
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Annie E. Casey Foundation
Casey Family Programs
MacArthur Foundation
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history